SCHEMBL771891

SCHEMBL771891

CCCCCCCCCCCCCCC=CI

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.54
TRPV1 Q8NER1 1/20 0.54
TERT O14746 3/20 0.52
PTPN1 P18031 3/20 0.52
PPARG P37231 3/20 0.52
PPARD Q03181 3/20 0.52
PPARA Q07869 3/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FABP4 P15090 2/20 0.52
KMT2A Q03164 2/20 0.52
TOP1 P11387 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9232315 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1615635 1.00
SCHEMBL1043632 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1043631 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14353253 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14830402 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL10868764 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14830401 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1904390 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL4062483 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10258559-B2 Preparation of a pulverulent/pasty composition comprising a silicone elastomer gel, solid particles and a binder phase, and lip treatment process L'OREAL (FR) 2019-04-16 US claimed
US-20230055352-A1 RE-CROSSLINKABLE PARTICLE FOR CONFORMANCE CONTROL AND TEMPORARY PLUGGING THE CURATORS OF THE UNIVERSITY OF MISSOURI 2023-02-23 US disclosed
WO-2021138073-A1 PROCESS FOR PREPARING AN ALPHA-SUBSTITUTED ACRYLATE DOW GLOBAL TECHNOLOGIES LLC (US) 2021-07-08 WO disclosed
US-20120070879-A1 REDUCTION OF ANTIBIOTIC ACTIVITY OR CONCENTRATION IN BIOLOGICAL SAMPLES USING MOLECULARLY IMPRINTED POLYMERS BECTON, DICKINSON AND COMPANY (US) 2012-03-22 US disclosed
WO-2010144348-A2 REDUCTION OF ANTIBIOTIC ACTIVITY OR CONCENTRATION IN BIOLOGICAL SAMPLES USING MOLECULARLY IMPRINTED POLYMERS BECTON, DICKINSON AND COMPANY (US) 2010-12-16 WO disclosed
EP-1569750-A1 MESOPOROUS MATERIAL WITH ACTIVE METALS ABB LUMMUS GLOBAL INC. (US) 2005-09-07 EP disclosed
US-20040249229-A1 Isomerization of olefins with carboxylic acid HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2004-12-09 US disclosed
WO-2004052537-A1 MESOPOROUS MATERIAL WITH ACTIVE METALS ABB LUMMUS GLOBAL INC. (US) 2004-06-24 WO disclosed
EP-1101798-B1 Thermally conductive silicone rubber composition DOW CORNING TORAY SILICONE (JP) 2003-08-13 EP disclosed
EP-0914076-A1 RINSE-OFF HAIR CARE COMPOSITIONS USING GRAFTED COPOLYMERS THE PROCTER & GAMBLE COMPANY (US) 1999-05-12 EP disclosed
WO-1997048740-A1 POLYOLEFIN MICROSPHERES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-12-24 WO disclosed
WO-1997034571-A1 RINSE-OFF HAIR CARE COMPOSITIONS USING GRAFTED COPOLYMERS THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
EP-0598543-A2 Method for producing Alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1994-05-25 EP disclosed
US-4618722-A Preparation of organic sulfides PHILLIPS PETROLEUM COMPANY (US) 1986-10-21 US disclosed
EP-0094050-A2 Ultrathin film, process for production thereof, and use thereof for concentrating a specified gas in a gaseous mixture TEIJIN LIMITED (JP) 1983-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10258559-B2 Preparation of a pulverulent/pasty composition comprising a silicone elastomer gel, solid particles and a binder phase, and lip treatment process PLOD3, PICALM, NONO FAAH 3535/4885TRPV1 1984/4885TERT 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.